文献速递关节外科

阿司匹林用于全髋与全膝关节置换术后静脉血栓栓塞预防:纳入外科医生选择偏倚的安全性及有效性分析

Aspirin for Venous Thromboembolic Prophylaxis Following Total Hip and Total Knee Arthroplasty: An Analysis of Safety and Efficacy Accounting for Surgeon Selection Bias.
PubMed 文献 · J Arthroplasty · 2023-03-03

本研究基于2015至2020年全国数据库,比较以外科医生阿司匹林使用率>90%与华法林使用率>90%划分的初次择期全膝关节置换(TKA)或全髋关节置换(THA)患者,采用工具变量分析校正选择偏倚。结果未发现阿司匹林与华法林在肺栓塞(PE)和深静脉血栓(DVT)风险上的差异,但阿司匹林组输血风险更低。

要点

  • 校正外科医生选择偏倚后,阿司匹林与华法林在TKA和THA术后PE风险上无显著差异。
  • 校正选择偏倚后,阿司匹林与华法林在TKA和THA术后DVT风险上无显著差异。
  • 阿司匹林组输血风险低于华法林组(TKA aOR=0.58,THA aOR=0.84,均P<.001)。

核心结论

  • 校正外科医生选择偏倚后,阿司匹林预防TKA和THA术后PE和DVT的效果与华法林相当。
  • 阿司匹林与华法林相比,输血风险更低。

研究设计与样本

  • 查询2015至2020年全国数据库,纳入初次择期TKA或THA患者。
  • 将外科医生在>90%患者中使用阿司匹林的患者与外科医生在>90%病例中使用华法林的患者进行比较。
  • 采用工具变量分析评估PE、DVT和输血,以校正选择偏倚。
  • TKA患者中,华法林队列26,657例(18.8%),阿司匹林队列115,005例(81.2%)。
  • THA患者中,华法林队列13,035例(17.7%),阿司匹林队列60,726例(82.3%)。

主要发现

  • TKA患者中,阿司匹林组与华法林组PE风险无显著差异(aOR=0.98,P=.659)。
  • THA患者中,阿司匹林组与华法林组PE风险无显著差异(aOR=0.93,P=.310)。
  • TKA患者中,阿司匹林组与华法林组DVT风险无显著差异(aOR=1.05,P=.188)。
  • THA患者中,阿司匹林组与华法林组DVT风险无显著差异(aOR=0.96,P=.493)。
  • 阿司匹林组输血风险低于华法林组(TKA:aOR=0.58,P<.001;THA:aOR=0.84,P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspirin may be effective at preventing venous thromboembolism following total knee arthroplasty (TKA) or total hip arthroplasty (THA). Current evidence is limited by bias as many surgeons who use aspirin prescribe for high-risk patients alternative chemoprophylactic agents. Therefore, this study aimed to evaluate the risk of pulmonary embolism (PE) and deep vein thrombosis (DVT) in patients who received aspirin and warfarin while accounting for surgeon selection bias. METHODS: A national database was queried for patients undergoing primary elective TKA or THA from 2015 to 2020. Patients whose surgeon used aspirin in >90% of their patients were compared to patients whose surgeon used warfarin in >90% of cases. Instrumental variable analyses were performed to assess for PE, DVT, and transfusion while accounting for selection bias. Among TKA patients, 26,657 (18.8%) were in the warfarin cohort and 115,005 (81.2%) were in the aspirin cohort. Among THA patients, 13,035 (17.7%) were in the warfarin cohort and 60,726 (82.3%) were in the aspirin cohort. RESULTS: Analyses were unable to identify a difference in the risk of PE (TKA: adjusted odds ratio [aOR]: 0.98, P = .659; THA: aOR = 0.93, P = .310) and DVT (TKA: aOR = 1.05, P = .188; THA: aOR = 0.96, P = .493) between the aspirin and warfarin cohorts. However, the aspirin cohort was associated with a lower risk of transfusion (TKA: aOR = 0.58, P < .001, THA: 0.84, P < .001). DISCUSSION: After accounting for surgeon selection bias, aspirin was as effective as warfarin at preventing PE and DVT following TKA and THA. Furthermore, aspirin was associated with a lower risk of transfusion compared to warfarin.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Heckmann ND, Piple AS, Wang JC, et al. Aspirin for Venous Thromboembolic Prophylaxis Following Total Hip and Total Knee Arthroplasty: An Analysis of Safety and Efficacy Accounting for Surgeon Selection Bias. J Arthroplasty. 2023. PMID: 36870517. doi:10.1016/j.arth.2023.02.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。